<DOC>
	<DOCNO>NCT03022695</DOCNO>
	<brief_summary>This monocenter , open-label , uncontrolled study accordance ยง23b MPG evaluate efficacy HIFU-treatment fibroadenoma use TH-One device .</brief_summary>
	<brief_title>Treatment Breast Fibroadenoma With High Intensity Focused Ultrasound ( HIFU )</brief_title>
	<detailed_description />
	<mesh_term>Fibroadenoma</mesh_term>
	<criteria>Female patient 18 year old least one diagnose breast fibroadenoma . Diagnosis fibroadenoma must base : clinical examination , woman โค 40 year age : ultrasound image alone ; woman &gt; 40 year age : ultrasound image mammogram , histological confirmation fibroadenoma breast . Patient 's fibroadenoma size determine ultrasound imaging : long diameter limit 25 mm . Women childbearing potential must negative urine pregnancy test within 72 hour prior HIFU treatment . Patient must able understand nature extent study procedure require willing able complete screen study procedure . Patient must give write informed consent ( personally sign date ) complete studyrelated procedure . Patient pregnant breastfeeding . Patient history ipsilateral breast cancer within 5 year prior study inclusion radio therapy target breast within 5 year prior study inclusion . Patient implant treat breast . Patient target fibroadenoma pretreated cryoablation interstitial laser therapy within 12 month recruit HIFU . Patient 's fibroadenoma clearly visible ultrasound image ( B mode ) inclusion visit . Patient participate study use drug medical device within 3 month prior study inclusion study participation include followup period .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>